During the last session, Mustang Bio Inc (NASDAQ:MBIO)’s traded shares were 0.41 million, with the beta value of the company hitting 1.84. The 52-week high for the MBIO share is $1.68, that puts it down -700.0 from that peak though still a striking 38.1% gain since the share price plummeted to a 52-week low of $0.13. The company’s market capitalization is $9.80M, and the average intraday trading volume over the past 10 days was 0.89 million shares, and the average trade volume was 1.85 million shares over the past three months.
Mustang Bio Inc (MBIO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. MBIO has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.16.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mustang Bio Inc (NASDAQ:MBIO) trade information
Mustang Bio Inc (MBIO) registered a -1.35% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.35% in intraday trading to $0.21, hitting a weekly high. The stock’s 5-day price performance is -10.16%, and it has moved by -29.37% in 30 days. Based on these gigs, the overall price performance for the year is -86.85%. The short interest in Mustang Bio Inc (NASDAQ:MBIO) is 0.53 million shares and it means that shorts have 0.15 day(s) to cover.
Mustang Bio Inc (MBIO) estimates and forecasts
Statistics show that Mustang Bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. Mustang Bio Inc (MBIO) shares have gone down -2.29% during the last six months, with a year-to-date growth rate more than the industry average at 86.50% against 17.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.87%. While earnings are projected to return 86.50% in 2024.
MBIO Dividends
Mustang Bio Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
Mustang Bio Inc insiders own 5.87% of total outstanding shares while institutional holders control 1.88%, with the float percentage being 1.99%.
Also, the Mutual Funds coming in first place with the largest holdings of Mustang Bio Inc (MBIO) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 190.52 shares. This amounts to just over 0.41 percent of the company’s overall shares, with a $39075.0 market value. The same data shows that the other fund manager holds slightly less at 73.42, or about 0.16% of the stock, which is worth about $15058.0.
